New study shows ecological benefits for enGenes Biotech -express technology
Media Center
Studies confirm usefulness of enGenes Biotech’s high quality SARS CoV-2 antigens
New enGenes Biotech study demonstrates benefits of new -express host strain for recombinant protein production
enGenes Biotech and TU Wien joint study demonstrates manufacturing benefits of extracellular secretion using -express technology
Antibiotic resistance marker-free protein production
enGenes Biotech brings latest downstream production solutions and COVID-19 antigens to BIO-Europe Digital
Research study on phage-inspired growth decoupled recombinant protein production in Escherichia coli
enGenes Biotech supports Vienna-based initiative to establish serology test for Covid-19
enGenes Biotech reaches proof-of-concept for -exPAND bioreactor scale non-canonical amino acid incorporation process
Improved gene expression in E. coli